|
KMID : 0368120130430080557
|
|
Korean Circulation Journal
2013 Volume.43 No. 8 p.557 ~ p.560
|
|
|
Acute Profound Thrombocytopenia after Using Abciximab for No-Reflow during Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction
|
|
Park Soon-Young
Lee Joo-young
Lee Sang-Yeub
Bae Jang-Whan
Hwang Kyung-Kuk
Kim Dong-Woon
Cho Myeong-Chan
Kim Sang-Min
|
|
|
Abstract
|
|
|
|
Glycoprotein IIb/IIIa antagonists are well established for their effectiveness in improving clinical outcomes in acute coronary syndrome patients undergoing percutaneous coronary intervention. Acute profound thrombocytopenia is a rare complication of abciximab. We present a case which was managed successfully for the rare complication of acute profound thrombocytopenia after using abciximab and an intra-aortic balloon pump for the treatment of a no-reflow phenomenon and consecutive cardiogenic shock during primary percutaneous coronary intervention.
|
|
|
KEYWORD
|
|
|
Thrombocytopenia, Abciximab, No-reflow phenomenon
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
   
|